Innovent Biologics Inc/ADR (IVBXF) research
Innovent Biologics Inc/ADR- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $12.51
- As of
Innovent Biologics Inc/ADR (IVBXF): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and no SEC filing for the company is on record.
As of . Source: SEC EDGAR filings for IVBXF. Method and limitations.
Share the IVBXF intelligence card
See the full IVBXF dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for IVBXF on one page. Preview it with sample data, then open it live with a free account.
Preview the IVBXF dossierActive signals for IVBXF
- mediumEARNINGS_BEAT
Q2-2026: Beat consensus by 98.2%, EPS $0.95 vs $0.4794 estimate
- mediumEARNINGS_BEAT
Q4-2023: Beat consensus by 59.6% - EPS $-0.206 vs $-0.51 estimate
- mediumEARNINGS_BEAT
Q2-2024: Beat consensus by 61.2% - EPS $-0.099 vs $-0.255 estimate
- mediumEARNINGS_BEAT
Beat consensus by 59.6% - EPS $-0.206 vs $-0.51 estimate
- mediumEARNINGS_BEAT
Beat consensus by 61.2% - EPS $-0.099 vs $-0.255 estimate
FREE, NO ACCOUNT
Every signal on IVBXF, as it fires
You are seeing 5 of 7 signals recorded on IVBXF since 2026-05-30.
The five above landed across 3 days. The other 2 were recorded on those same days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Related tickers
See more IVBXF signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to IVBXFand get the insider, 13F, options, and confluence read in one view.